IRIS
VALENTINI, Gabriele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 12.209
NA - Nord America 5.611
AS - Asia 1.013
SA - Sud America 17
Continente sconosciuto - Info sul continente non disponibili 14
AF - Africa 4
OC - Oceania 2
Totale 18.870
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 6.463
US - Stati Uniti d'America 5.531
IE - Irlanda 1.846
UA - Ucraina 1.115
GB - Regno Unito 776
FR - Francia 537
DE - Germania 510
CN - Cina 371
SG - Singapore 346
FI - Finlandia 280
SE - Svezia 250
GR - Grecia 193
TR - Turchia 190
CA - Canada 77
BE - Belgio 69
KR - Corea 39
ES - Italia 38
NL - Olanda 30
IN - India 26
CH - Svizzera 22
PL - Polonia 20
BR - Brasile 12
EU - Europa 12
ID - Indonesia 10
RO - Romania 9
RU - Federazione Russa 9
AT - Austria 8
CZ - Repubblica Ceca 8
TW - Taiwan 8
HR - Croazia 7
HK - Hong Kong 5
HU - Ungheria 5
JP - Giappone 5
BY - Bielorussia 3
EC - Ecuador 3
AP - ???statistics.table.value.countryCode.AP??? 2
AU - Australia 2
DK - Danimarca 2
EG - Egitto 2
IQ - Iraq 2
IR - Iran 2
MK - Macedonia 2
MX - Messico 2
NO - Norvegia 2
PH - Filippine 2
ZA - Sudafrica 2
BD - Bangladesh 1
BG - Bulgaria 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LT - Lituania 1
MY - Malesia 1
PA - Panama 1
PE - Perù 1
PK - Pakistan 1
PT - Portogallo 1
PY - Paraguay 1
RS - Serbia 1
SM - San Marino 1
TH - Thailandia 1
VN - Vietnam 1
Totale 18.870
Salva come PNG Salva come JPEG
Città #
Dublin 1.840
Jacksonville 1.574
Chandler 756
Rome 375
Milan 317
Santa Clara 301
Princeton 288
Medford 254
Singapore 219
Ann Arbor 166
Napoli 156
San Mateo 152
Boardman 148
Roxbury 148
Beijing 144
Wilmington 138
Naples 123
Bremen 113
Woodbridge 113
Cambridge 82
Florence 79
Palermo 72
Turin 71
Des Moines 64
Mountain View 64
Brussels 62
Caserta 56
Ottawa 51
Catania 50
Nanjing 48
Padova 48
Bari 46
Ashburn 40
Bologna 40
New York 38
Seoul 35
Torino 27
Verona 27
Helsinki 25
Mcallen 23
Pescara 23
Genoa 21
Houston 21
Redwood City 21
Cagliari 20
Jinan 19
Messina 19
Venice 19
Dallas 18
Genova 18
Brescia 17
Düsseldorf 17
Kunming 17
Norwalk 17
Vicenza 17
Taranto 16
Trieste 16
Gorno 15
Livorno 15
Parma 15
Auburn Hills 14
Reggio Calabria 14
Salerno 14
Falls Church 13
Hebei 13
Montréal 12
Munich 12
Perugia 12
Belluno 11
Guangzhou 11
Hanover 11
Nanchang 11
Ningbo 11
Terni 11
Torre del Greco 11
Trento 11
Varese 11
Bergamo 10
Fiano Romano 10
Lanzhou 10
Mykolayiv 10
Reggio Emilia 10
Bastia umbra 9
Bolzano 9
Catanzaro 9
Cosenza 9
Lecce 9
Lucca 9
Marano Di Napoli 9
Rimini 9
Assisi 8
Aversa 8
Barcelona 8
Brno 8
Carbonera 8
Hefei 8
Latina 8
Los Angeles 8
Modena 8
Monza 8
Totale 9.139
Salva come PNG Salva come JPEG
Nome #
ARTRITE PSORIASICA ED INTERSTIZIOPATIA POLMONARE : DESCRIZIONE DI UN CASO CLINICO. 6.535
ANTI TNF ALFA IN PAZIENTI AFFETTI DA ARTRITE REUMATOIDE E SPONDILOARTRITI HBV CARRIERS OCCULTI:STUDIO RETROSPETTIVO SULLA SICUREZZA 200
A PILOT STUDY ON LOW-DOSE INTRAVENOUS CICLOPHOSPHAMIDE IN SYSTEMIC SCLEROSIS: EFFICACY, SAFETY AND EFFECTS ON CELLULAR ACTIVATION MARKERS 105
Association between a stromal cell-derived factor 1 (SDF-1/CXCL12) gene polymorphism and microvascular disease in systemic sclerosis 91
ANTI-TNFα TREATMENT IS ASSOCIATED WITH INCREASED LIVER STIFFNESS IN HBV OCCULT CARRIER PATIENTS 87
Antinuclear antibodies in first-degree relatives of patients with polymyositis-dermatomyositis: analysis of the relationship with HLA haplotypes 81
Early Systemic Sclerosis: Marker Autoantibody Positive Patients Have A Faster Pace Of The Disease. 81
Polymorphism of immunoglobulin enhancer element HS1,2A: allele *2 associates with systemic sclerosis. Comparison with HLA-DR and DQ allele frequency 80
Diagnostic issues faced by a rare disease healthcare network during Covid-19 outbreak: data from the Campania Rare Disease Registry 80
Clinical and subclinical atherosclerosis in systemic sclerosis: consequences of previous corticosteroid treatment. 79
[HAQ-DI Italian version in systemic sclerosis]. 77
Early systemic sclerosis: Analysis of the disease course in patients with marker autoantibody or capillaroscopic positivity or both. 76
Clinical correlates of human leukocyte antigen-G (HLA-G) in systemic sclerosis. 76
Peripheral blood T lymphocytes from systemic sclerosis patients show both Th1 and Th2 activation 75
PREVALENCE OF ANTIBODIES RECOGNAIZING CYCLIC CITRULLINATED PEPTIDE(anti CCP) IN PATIENTS WITH ULCERATIVE COLITIS 68
EUSTAR biobanking: recommendations for the collection, storage and distribution of biospecimens in scleroderma research 67
-238 and +489 TNF-alpha along with TNF-RII gene polymorphisms associate with the diffuse phenotype in patients with Systemic Sclerosis 67
[T-lymphocyte subpopulations in the conjunctiva of subjects with secondary Sjogren's syndrome] 66
CXCL4 in undifferentiated connective tissue disease at risk for systemic sclerosis (SSc) (previously referred to as very early SSc) 65
Alterazioni del sistema nervoso autonomo nella Sclerosi Sistemica (SSc). Risultati preliminari di uno studio sul rapporto con la severita della malattia 64
.ANTI-TNF alfa IN PATIENTS WITH EITHER RHEUMATOID ARTHRITIS OR SPONYLOATHRITIS And CONCURRENT C HEPATITIS:A RETROSPECTIVE RECORD REVIEW ON SAFETY 64
Sub-Analysis of ELF Score Biomarkers Components Indicates a Specific Correlation with Different Organ Involvement in Systemic Sclerosis. 63
Adult-onset Still's disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients 63
Evaluation of cardiac structures and function in systemic sclerosis by Doppler echocardiography 62
Association of a functional polymorphism in the matrix metalloproteinase-12 promoter region with systemic sclerosis in an Italian population 61
Anti-centromere protein A antibodies in systemic sclerosis: Significance and origin 61
Prevalence of anti-toxoplasma antibodies in patients with autoimmune diseases. 60
Tissue Doppler imaging in systemic sclerosis: A 3-year longitudinal study. 60
Cardiac involvement in rheumatoid arthritis: an echocardiographic study 60
Early systemic sclerosis: marker autoantibodies and videocapillaroscopy patterns are each associated with distinct clinical, functional and cellular activation markers. 60
[Comparison between auranofin and chloroquine in the therapy of rheumatoid arthritis] 60
Assessment of intestinal permeability and orocecal transit time in patients with systemic sclerosis 59
ARTHRITIS IS ASSOCIATED WITH PSORIASIS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES 59
ATHEROSCLEROSIS AND RHEUMATOID ARTHRITIS: EVALUATION OF INTIMA-MEDIA THICKNESS AND CORRELATION WITH INFLAMMATORY AND ATHEROGENIC MARKERS 59
ELF Score: A Validated Serum Test Strongly Predictive of Fibrosis in Systemic Sclerosis. 59
RELATIONSHIP OF THE 6-MIN WALKING TEST AND QUALITY OF LIFE 59
Low-dose intravenous cyclophosphamide in systemic sclerosis: an open prospective efficacy study in patients with early diffuse disease 58
Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database 57
Glucocorticoids in systemic sclerosis: weighing the benefits and risks - a systematic review 57
Succesfull neridronate therapy in transient osteoporosis of the hip 57
Systemic sclerosis could mask the presentation of psoriasis in a patient with symptomatic and bilateral sacroiliitis 57
Crioglobulinemia mista essenziale: prevalenza e caratteri della neuropatia periferica 57
Longterm Hydroxychloroquine Therapy and Low-dose Aspirin May Have an Additive Effectiveness in the Primary Prevention of Cardiovascular Events in Patients with Systemic Lupus Erythematosus 57
Effects and safety of rituximab in systemic sclerosis: An analysis from the European Scleroderma Trial and Research (EUSTAR) group 56
Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients 56
Alterazione del riempimento ventricolare sinistro nella sclerosi sistemica (SSc): risultati di uno studio Iongitudinale 56
Morphea developing in patients previously affected with eosinophilic fasciitis. Report of two cases 56
Cell-free DNA in the plasma of patients with systemic sclerosis 55
[Italian consensus on the recommendations about the use of methotrexate for the treatment of rheumatic diseases with a focus on rheumatoid arthritis: results from the "3E initiative"]. 55
High IL-17E and Low IL-17C Dermal Expression Identifies a Fibrosis-Specific Motif Common to Morphea and Systemic Sclerosis. 55
Impaired exercise performance in systemic sclerosis and its clinical correlations 55
Early systemic sclerosis: assessment of clinical and pre-clinical organ involvement in patients with different disease features 55
Adult-onset Still's disease: Evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers 55
Prevalence and factors associated with glucocorticoids (GC) use in systemic sclerosis (SSc): a systematic review and meta-analysis of cohort studies and registries 54
[A comparison between the Simplified Disease Activity Index (SDAI) and the Disease Activity Score (DAS28) as measure of response to treatment in patients undergoing different therapeutic regimens]. 54
Association of the CD226 Ser(307) variant with systemic sclerosis: evidence of a contribution of costimulation pathways in systemic sclerosis pathogenesis 54
Increased expression of CD40 ligand in activated CD4+ T lymphocytes of systemic sclerosis patients 54
Serological and clinical markers of autoimmune disease in HCV-infected subjects with different disease conditions 54
Low-dose pulse cyclophosphamide in interstitial lung disease associated with systemic sclerosis (SSc-ILD): Efficacy of maintenance immunosuppression in responders and non-responders. 54
[Survival and death causes in 251 systemic sclerosis patients from a single Italian center]. 54
ANTI-TOPOISOMERASE I (ANTI-SCL-70) AND CANCER IN SYSTEMIC SCLEROSIS. ARE THEY RELATED? 54
VALIDATION OF THE SIMPLIFIED DISEASE ACTIVITY INDEX (SDAI) AND DAS28 AS MEASURE OF RESPONSE TO TREATMENT IN PATIENTS UNDERGOING DIFFERENT THERAPEUTIC REGIMENS 54
Low-dose aspirin as primary prophylaxis for cardiovascular events in systemic lupus erythematosus: A long-term retrospective cohort study 54
Glucocorticoids in systemic sclerosis: patients' beliefs and treatment adherence. 53
RELAPSING POLYCHONDRITIS. AN HYSTOCHEMICAL STUDY BY LECTIN. 53
Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative 53
Peripheral T lymphocytes from patients with early systemic sclerosis co-cultured with autologous fibroblasts undergo an oligoclonal expansion similar to that occurring in the skin 53
Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group 53
Diastolic abnormalities in systemic sclerosis: evidence for associated defective cardiac functional reserve 53
Right atrial morphology and function in patients with systemic sclerosis compared to healthy controls: a two-dimensional strain study 53
New strategies to address the pharmacodynamics and pharmacokinetics of tumor necrosis factor (TNF) inhibitors: A systematic analysis. 52
Evidence for peripheral impaired glucose handling in patients with connective tissue diseases 52
The -670G>A polymorphism in the FAS gene promoter region influences the susceptibility to systemic sclerosis. 52
Factors influencing pain, physical function and social functioning in patients with osteoarthritis in southern Italy. 52
EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR) 52
Early Systemic Sclerosis: Serum Profiling of Factors Involved in Endothelial, T-cell, and Fibroblast Interplay is Marked by Elevated Interleukin-33 Levels. 52
Thrombocytosis in progressive generalized sclerosis (scleroderma) and in other rheumatic diseases 52
[Absolute and relative increase in Leu-11b+ cells in patients with systemic scleroderma] 52
The incidence of cardiovascular events in Italian patients with systemic lupus erythematosus is lower than in North European and American cohorts: Implication of disease-associated and traditional risk factors as emerged by a 16-year retrospective GIRRCS study 52
ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis-a EUSTAR analysis. 52
Correlations of Y chromosome microchimerism with disease activity in patients with SLE: analysis of preliminary data 51
[Copernican revolution in the therapy of rheumatoid arthritis: the contribution of anti-TNFalpha drugs]. 51
Twelve-month azathioprine as maintenance therapy in early diffuse systemic sclerosis patients treated for 1-year with low dose cyclophosphamide pulse therapy 51
Quality of life as measured by the short-form 36 (SF-36) questionnaire in patients with early systemic sclerosis and undifferentiated connective tissue disease. 51
Anti-inflammatory: new trends in the treatment of the patient with systemic sclerosis 51
European Scleroderma Study Group (ESCSG) Activity Index is correlated to quality of life measures both at admission and overtime 51
Brief report: Successful pregnancies but a higher risk of preterm births in systemic sclerosis: An Italian multicentric study. 51
Cardiac involvement in undifferentiated connective tissue disease at risk for systemic sclerosis (otherwise referred to as very early-early systemic sclerosis): a TDI study 51
The use of monoclonal antibody against alpha-1 antitripsin in diagnostic screening of inflammatory disorders 50
Disease remission and sustained halting of radiographic progression with combination etanercept and methotrexate in patients with rheumatoid arthritis 50
The challenge of early systemic sclerosis for the EULAR Scleroderma Trial and Research group (EUSTAR) community. It is time to cut the Gordian knot and develop a prevention or rescue strategy 50
Good clinical response, remission, and predictors of remission in rheumatoid arthritis patients treated with tumor necrosis factor-alpha blockers: the GISEA study 50
The assessment of the patient with systemic sclerosis. Introduction 50
Aggressive rheumatoid arthritis registry in Italy. Characteristics of the early rheumatoid arthritis subtype among patients classified according to the ACR criteria 50
The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: Derivation and validation of a preliminarily revised EUSTAR activity index 50
Scleroderma renal crisis analysis of prevalence and outcome in a large italian series. 49
[Hypocomplementemia in systemic sclerosis]. 49
Association of a KCNA5 gene polymorphism with systemic sclerosis-associated pulmonary arterial hypertension in the European Caucasian population 48
Studio neurofisiologico in 17 casi di crioglobulinemia. Rivista Italiana di EEG e Neurofisiologia Clinica : , 48
Pregnancy and systemic sclerosis 48
Totale 12.474
Salva come PNG Salva come JPEG
Categoria #
all - tutte 65.943
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.943
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.578 0 0 0 0 303 102 422 181 251 127 106 86
2020/20213.086 282 76 331 164 466 111 381 316 137 363 312 147
2021/20222.634 245 77 93 103 738 103 106 162 134 120 201 552
2022/20234.527 430 195 113 303 394 316 112 297 1.767 184 204 212
2023/20242.785 195 131 182 285 626 109 189 230 130 161 228 319
2024/20251.070 125 162 120 195 468 0 0 0 0 0 0 0
Totale 19.461